Androgen Deprivation Therapy Clinical Trials

8 recruiting

Androgen Deprivation Therapy Trials at a Glance

9 actively recruiting trials for androgen deprivation therapy are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Fuenlabrada, and Burlington. Lead sponsors running androgen deprivation therapy studies include Dana-Farber Cancer Institute, Inova Health Care Services, and Brenton Baguley.

Browse androgen deprivation therapy trials by phase

Treatments under study

About Androgen Deprivation Therapy Clinical Trials

Looking for clinical trials for Androgen Deprivation Therapy? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Androgen Deprivation Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Androgen Deprivation Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Prostate CancerProstate CarcinomaProstate Neoplasm+12 more
Shehzad Basaria, M.D.60 enrolled1 locationNCT06957691
Recruiting
Phase 1

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma46 enrolled1 locationNCT06130995
Recruiting
Phase 2

Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer

Androgen Deprivation TherapyProstate CA
University of Vermont32 enrolled1 locationNCT06972875
Recruiting
Not Applicable

Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture

Hot FlashesVasomotor SymptomsAndrogen Deprivation Therapy+2 more
Inova Health Care Services24 enrolled1 locationNCT07335224
Recruiting
Not Applicable

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

Prostate CancerProstate Cancer MetastaticAndrogen Deprivation Therapy
Dana-Farber Cancer Institute62 enrolled1 locationNCT05327465
Recruiting
Not Applicable

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

Prostate CancerMetastatic Prostate CancerAndrogen Deprivation Therapy
University of Utah74 enrolled1 locationNCT07032584
Recruiting
Phase 3

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

Prostate CancerAndrogen Deprivation TherapyBiochemical Recurrence+2 more
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic534 enrolled17 locationsNCT05781217
Recruiting
Phase 2

A Novel Liver Targeted Testosterone Therapy for Sarcopenia in Androgen Deprived Men with Prostate Cancer - A Blinded Randomized Controlled Trial

SarcopeniaProstate CancerAndrogen Deprivation Therapy
Metro South Health and Hospital Service50 enrolled2 locationsACTRN12616001166460
Recruiting

Evaluation of diet and exercise in prostate cancer-related fatigue

Prostate Cancer treated with Androgen Deprivation therapy
Brenton Baguley116 enrolled1 locationACTRN12615000512527